• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ST. JUDE MEDICAL, INC.(CRM-SYLMAR) CD2257-40Q FORTIFY ASSURA DR ICD_IDE_US; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ST. JUDE MEDICAL, INC.(CRM-SYLMAR) CD2257-40Q FORTIFY ASSURA DR ICD_IDE_US; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR Back to Search Results
Model Number CD2257-40Q
Medical Device Problem Code Premature Discharge of Battery (1057)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 12/07/2022
Type of Reportable Event Serious Injury
Event or Problem Description
It was reported that a patient presented remotely on (b)(6) 2022 with their implantable cardioverter defibrillator (icd) at elective replacement indicator (eri), despite having had 9 months of remaining longevity during the last check in (b)(6) 2022.Premature battery depletion was suspected.The patient's icd was explanted and replaced on (b)(6) 2022.The patient was stable throughout.
 
Additional Manufacturer Narrative
Premature battery depletion was confirmed by analysis.No sources of high current were noted.The cause of the premature battery depletion was consistent with lithium (li) cluster formation.From these analyses, in the absence of high current draw, it is probable that the premature battery depletion was caused by a lithium cluster induced short circuit.Li clusters are a known depletion mechanism for these advisory products that has been investigated and associated with a field action in october 2016.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CD2257-40Q FORTIFY ASSURA DR ICD_IDE_US
Common Device Name
IMPLANTABLE CARDIOVERTER DEFIBRILLATOR
Manufacturer (Section D)
ST. JUDE MEDICAL, INC.(CRM-SYLMAR)
15900 valley view court
sylmar CA 91342
Manufacturer (Section G)
ST. JUDE MEDICAL, INC.(CRM-SYLMAR)
15900 valley view court
sylmar CA 91342
Manufacturer Contact
richard williamson
15900 valley view court
sylmar, CA 91342
MDR Report Key16045630
Report Number2017865-2022-50734
Device Sequence Number20064762
Product Code NVZ
UDI-Device Identifier05414734505550
UDI-Public05414734505550
Combination Product (Y/N)N
Initial Reporter StateNY
Initial Reporter CountryUS
PMA/510(K) Number
P910023
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2013
Device Explanted Year2022
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Health Professional,User Facility,Company Representative
Initial Reporter Occupation Nurse
Remedial Action Recall
Type of Report Initial,Followup
Report Date (Section B) 02/03/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date08/31/2014
Device Model NumberCD2257-40Q
Device Catalogue NumberCD2257-40Q
Device Lot Number3955368
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 12/09/2022
Supplement Date Received by Manufacturer02/03/2023
Initial Report FDA Received Date12/23/2022
Supplement Report FDA Received Date02/03/2023
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured02/17/2013
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
If action reported to FDA under 21 USC 360i(g), list
FDA-assigned Recall Number or include a statement
Z-0115-2017
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
DURATA RIGHT VENTRICULAR LEAD; TENDRIL RIGHT ATRIAL LEAD
Outcome Attributed to Adverse Event Required Intervention;
Patient Age65 YR
Patient SexMale
-
-